The treatment gap in epilepsy: the current situation and ways forward.
This article is a summary of a workshop held by the ILAE concerning the issue of the epilepsy treatment gap in developing countries. The gap is defined in terms of those people with epilepsy who are not being appropriately treated and is the result of an array of medical, political, social, economic, and cultural factors. The situation regarding the treatment gap for various countries is reviewed, along with some of its causes. Although the overall gap is estimated to be large, a number of recent projects and interventions have been effective in delivering appropriate treatment to people with epilepsy in underresourced countries of the developing world. It is hoped that these may be transferable elsewhere and that, combined with the ILAE/IBE/WHO Global Campaign against Epilepsy and increased support from the worldwide epilepsy community, the treatment gap will begin to be bridged.
Meinardi
H
H
Department of Physiology, Leyden University Medical Centre, P.O. Box 9604, 2300 RC Leiden, The Netherlands. meinardi@wxs.nl
Scott
R A
RA
Reis
R
R
Sander
J W
JW
D000927:Anticonvulsants / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000592:standards*; D003906:Developing Countries / Q000706:statistics & numerical data*; D004827:Epilepsy / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D014943:Global Health; D006801:Humans; D011634:Public Health / Q000592:standards
D000927:Anticonvulsants